Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

Lab Market Is Fragmenting, Creating New Opportunities

Also in the April 8, 2024 issue, the FDA issues a memo to reclassify many high risk IVD assays

Even as consolidation continues in the ownership of hospitals, health systems, office-based physicians, and clinical laboratories, there is a powerful trend of fragmentation quietly transforming the way providers—including clinical labs and pathology groups—serve patients and consumers who want specialized expertise and choice. Today’s market for clinical laboratory testing services is fragmenting at a pace that […]

To access this post, you must purchase The Dark Report.

Comments

;